Frontiers in Pharmacology | Pharmacoepidemiology

Systematic Review

Published on 10 Oct 2024

A systematic review and meta-analysis of the efficacy and safety of iguratimod in the treatment of inflammatory arthritis and degenerative arthritis

in Pharmacoepidemiology

Zhiyong Long
Liuting Zeng
Kailin Yang
Junpeng Chen
Yanfang Luo
Charles C. Dai
Qi He
Ying Deng
Anqi Ge
Xiaofei Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1440584

4,880 views
4 citations

Systematic Review

Published on 26 Sep 2024

Global research on sufentanil use in anesthesiology from 2003 to 2023: a bibliometric analysis

in Pharmacoepidemiology

Duoqin Huang
Zixin Luo
Xinyue Song
Kang Zou

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1412726

4,469 views
8 citations

Original Research

Published on 24 Sep 2024

Development and validation of a clinical prediction model for osteonecrosis of the jaw in patients receiving zoledronic acid using FAERS and canadian databases

in Pharmacoepidemiology

Zhen Wei
Chuan Hong
Chunhui Tu
Wukun Ge
Yaoyao Hu
Shuainan Lin

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1456900

4,818 views
2 citations

Original Research

Published on 20 Sep 2024

A real-world pharmacovigilance analysis of eslicarbazepine acetate using the FDA adverse events reporting system (FAERS) database from 2013 (Q4) to 2024 (Q1)

in Pharmacoepidemiology

Huafei Tang
Jing Xu
Xian Zhang
Chunliang Chen
Ge Song
Rui Ma
Jinjing Zhao
Qiang Zhao

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1463560

4,228 views
4 citations

Original Research

Published on 19 Sep 2024

Exploring bleeding in oral anticoagulant users: assessing incidence by indications and risk factors in the entire nationwide cohort

in Pharmacoepidemiology

Jonghyun Jeong
Kyu-Nam Heo
Suhyun Lee
Young-Mi Ah
Sangil Min
Ji Min Han
Ju-Yeun Lee

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1399955

4,811 views
8 citations

Original Research

Published on 19 Sep 2024

Comparative safety analysis of lacosamide and perampanel in epilepsy management: insights from FAERS database

in Pharmacoepidemiology

Chang Ge
Liuyin Jin
Jing-Jing Tian
Na Yang
Jian Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1418609

4,532 views
7 citations

Original Research

Published on 16 Sep 2024

Rhabdomyolysis associated with concomitant use of colchicine and statins in the real world: identifying the likelihood of drug–drug interactions through the FDA adverse event reporting system

in Pharmacoepidemiology

Sha Zhang
Ming-Ming Yan
Hui Zhao
Xiao-Yan Qiu
Deqiu Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1445324

10,381 views
4 citations

Original Research

Published on 16 Sep 2024

Highly active antiretroviral therapy adherence among HIV-POSITIVE women in Southern Ethiopia

in Pharmacoepidemiology

Alemayehu Abebe Demissie
Elsie Janse van Rensburg

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1420979

2,060 views
2 citations

Systematic Review

Published on 13 Sep 2024

Exploring medication self-management in polypharmacy: a qualitative systematic review of patients and healthcare providers perspectives

in Pharmacoepidemiology

Ran Jin
Caiyan Liu
Jinghao Chen
Mengjiao Cui
Bo Xu
Ping Yuan
Lu Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1426777

7,937 views
5 citations

Original Research

Published on 10 Sep 2024

Potentially inappropriate prescribing in polymedicated older adults with atrial fibrillation and multimorbidity: a Swedish national register-based cohort study

in Pharmacoepidemiology

Cheima Amrouch
Davide Liborio Vetrano
Cecilia Damiano
Lu Dai
Amaia Calderón-Larrañaga
Maxim Grymonprez
Marco Proietti
Gregory Y. H. Lip
Søren P. Johnsen
Jonas W. Wastesson

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1476464

4,068 views
8 citations

Original Research

Published on 09 Sep 2024

Tumor lysis syndrome signal with the combination of encorafenib and binimetinib for malignant melanoma: a pharmacovigilance study using data from the FAERS database

in Pharmacoepidemiology

Shuang Xia
Jing-Wen Xu
Kang-Xin Yan
Yoshihiro Noguchi
Mayur Sarangdhar
Miao Yan

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1413154

4,257 views
1 citation

Original Research

Published on 06 Sep 2024

Suspected adverse drug reactions of rivaroxaban reported in the United States food and drug administration adverse event reporting system database: a pharmacovigilance study

in Pharmacoepidemiology

Jingying Wu
Jianru Wu
Biyu Tang
Xinru Wang
Fenfang Wei
Yi Zhang
Limin Li
Hongqiao Li
Bei Wang
Wenyu Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1399172

5,582 views
7 citations

Original Research

Published on 04 Sep 2024

Insights from pharmacovigilance and pharmacodynamics on cardiovascular safety signals of NSAIDs

in Pharmacoepidemiology

Shuang Liang
Xianying Wang
Xiuqing Zhu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1455212

6,552 views
7 citations

Original Research

Published on 04 Sep 2024

A discovery and verification approach to pharmacovigilance using electronic healthcare data

in Pharmacoepidemiology

Louis Dijkstra
Tania Schink
Roland Linder
Markus Schwaninger
Iris Pigeot
Marvin N. Wright
Ronja Foraita

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1426323

3,285 views
4 citations

Original Research

Published on 29 Aug 2024

Repurposing antihypertensive drugs for pain disorders: a drug-target mendelian randomization study

in Pharmacoepidemiology

Kai Du
Ao Li
Chen-Yu Zhang
Shu-Ming Li
Ping Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1448319

5,530 views
3 citations

Systematic Review

Published on 23 Aug 2024

Associated factors with voriconazole plasma concentration: a systematic review and meta-analysis

in Pharmacoepidemiology

Xiaoqi Li
Qiaozhi Hu
Ting Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1368274

3,771 views
5 citations

Original Research

Published on 22 Aug 2024

Dexmedetomidine administration is associated with improved outcomes in critically ill patients with acute myocardial infarction partly through its anti-inflammatory activity

in Pharmacoepidemiology

Yimou Liu
Qian Chen
Tianyang Hu
Changming Deng
Jing Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1428210

4,364 views
9 citations

Editorial

Published on 20 Aug 2024

Editorial: Pharmacoepidemiology and pharmacovigilance post-marketing drug safety studies

in Pharmacoepidemiology

Zakir Khan
Yusuf Karatas
Ahmet Akici
Maria Auxiliadora Parreiras Martins
Nafees Ahmad

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1473052

5,958 views

Original Research

Published on 13 Aug 2024

A real-world disproportionality analysis of sacubitril/valsartan: data mining of the FDA adverse event reporting system

in Pharmacoepidemiology

Yiwen Wang
Xuna Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1392263

3,648 views
6 citations

Original Research

Published on 13 Aug 2024

Efficient analysis of adverse drug events and toxicological mechanisms of newly marketed drugs by integrating pharmacovigilance and network toxicology: selumetinib as an example

in Pharmacoepidemiology

Rui Xiong
Jing Lei
Lu Wang
Shipeng Zhang
Hengxu Liu
Hongping Wang
Tao Liu
Xiaodan Lai

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1432759

8,608 views
12 citations

Systematic Review

Published on 31 Jul 2024

Status and hotspot analysis of Qingfei Paidu Decoction for the prevention and treatment of COVID-19 based on bibliometric analysis

in Pharmacoepidemiology

Huifang Zhang
Yang Liu
Xiyu Shang
Yuqing Cao
Jiajia Li
Guangkun Chen
Xinyu Ji
Lei Zhang
Yipin Fan
Yan Ma

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1422773

3,594 views
3 citations

Original Research

Published on 31 Jul 2024

The association between continuous polypharmacy and hospitalization, emergency department visits, and death in older adults: a nationwide large cohort study

in Pharmacoepidemiology

Jungmi Chae
Ho Jin Cho
Sang-Heon Yoon
Dong-Sook Kim

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1382990

6,583 views
14 citations

Original Research

Published on 26 Jul 2024

Safety profiles of doxycycline, minocycline, and tigecycline in pediatric patients: a real-world pharmacovigilance analysis based on the FAERS database

in Pharmacoepidemiology

Yanli Qiao
Yechao Chen
Qiaoyun Wang
Jingrui Liu
Xiaohui Guo
Qiaoling Gu
Peng Ding
Haixia Zhang
Hongliang Mei

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1413944

10,581 views
7 citations

Original Research

Published on 24 Jul 2024

Seriousness and outcomes of reported adverse drug reactions in old and new antiseizure medications: a pharmacovigilance study using EudraVigilance database

in Pharmacoepidemiology

Michael Magdy Fahmy Girgis
Gergely Farkasinszky
Klára Fekete
István Fekete
Miklós Vecsernyés
Ildikó Bácskay
László Horváth

Frontiers in Pharmacology

doi 10.3389/fphar.2024.1411134

3,446 views
3 citations

601 articles

articles

A systematic review and meta-analysis of the efficacy and safety of iguratimod in the treatment of inflammatory arthritis and degenerative arthritis

Global research on sufentanil use in anesthesiology from 2003 to 2023: a bibliometric analysis

Development and validation of a clinical prediction model for osteonecrosis of the jaw in patients receiving zoledronic acid using FAERS and canadian databases

A real-world pharmacovigilance analysis of eslicarbazepine acetate using the FDA adverse events reporting system (FAERS) database from 2013 (Q4) to 2024 (Q1)

Exploring bleeding in oral anticoagulant users: assessing incidence by indications and risk factors in the entire nationwide cohort

Comparative safety analysis of lacosamide and perampanel in epilepsy management: insights from FAERS database

Rhabdomyolysis associated with concomitant use of colchicine and statins in the real world: identifying the likelihood of drug–drug interactions through the FDA adverse event reporting system

Highly active antiretroviral therapy adherence among HIV-POSITIVE women in Southern Ethiopia

Exploring medication self-management in polypharmacy: a qualitative systematic review of patients and healthcare providers perspectives

Potentially inappropriate prescribing in polymedicated older adults with atrial fibrillation and multimorbidity: a Swedish national register-based cohort study

Tumor lysis syndrome signal with the combination of encorafenib and binimetinib for malignant melanoma: a pharmacovigilance study using data from the FAERS database

Suspected adverse drug reactions of rivaroxaban reported in the United States food and drug administration adverse event reporting system database: a pharmacovigilance study

Insights from pharmacovigilance and pharmacodynamics on cardiovascular safety signals of NSAIDs

A discovery and verification approach to pharmacovigilance using electronic healthcare data

Repurposing antihypertensive drugs for pain disorders: a drug-target mendelian randomization study

Associated factors with voriconazole plasma concentration: a systematic review and meta-analysis

Dexmedetomidine administration is associated with improved outcomes in critically ill patients with acute myocardial infarction partly through its anti-inflammatory activity

Editorial: Pharmacoepidemiology and pharmacovigilance post-marketing drug safety studies

A real-world disproportionality analysis of sacubitril/valsartan: data mining of the FDA adverse event reporting system

Efficient analysis of adverse drug events and toxicological mechanisms of newly marketed drugs by integrating pharmacovigilance and network toxicology: selumetinib as an example

Status and hotspot analysis of Qingfei Paidu Decoction for the prevention and treatment of COVID-19 based on bibliometric analysis

The association between continuous polypharmacy and hospitalization, emergency department visits, and death in older adults: a nationwide large cohort study

Safety profiles of doxycycline, minocycline, and tigecycline in pediatric patients: a real-world pharmacovigilance analysis based on the FAERS database

Seriousness and outcomes of reported adverse drug reactions in old and new antiseizure medications: a pharmacovigilance study using EudraVigilance database